Matinas BioPharma Holdings, Inc. (MTNB) EPS by Year
MTNB
Matinas BioPharma Holdings, Inc. lost $2.00 per diluted share in fiscal year 2025. This represents an increase of 59.8% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Matinas BioPharma Holdings, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$2.00
YoY+59.8%
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
MTNB EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Matinas BioPharma Holdings, Inc.'s diluted earnings per share in fiscal year 2025?
Matinas BioPharma Holdings, Inc. lost $2.00 per diluted share in fiscal year 2025.
How fast is Matinas BioPharma Holdings, Inc.'s diluted earnings per share growing?
Matinas BioPharma Holdings, Inc. (MTNB) diluted earnings per share rose by 59.8% year over year, from -$4.98 to -$2.00 in fiscal year 2025.
What was Matinas BioPharma Holdings, Inc.'s diluted earnings per share in the most recent quarter?
Matinas BioPharma Holdings, Inc. (MTNB) reported -$0.21 in diluted earnings per share in Q2 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Matinas BioPharma Holdings, Inc. (MTNB) reported on that line in every period on record.
